Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension

200580 citationsJournal Article

Authors

E. Randy Craven · Glaucoma Associates of Texas

Thomas R. Walters

Robert D. Williams · Taustine Eye Center

Connie Chou · Allergan (Ireland)

Janet K. Cheetham · Allergan (United States)

Rhett M. Schiffman · Allergan (Ireland)

Combigan Study Group

Abstract

The fixed combination of brimonidine and timolol was well-tolerated and provided significantly better IOP control compared with either brimonidine or timolol used alone.

Topics & Keywords

Glaucoma and retinal disorders Retinal Diseases and Treatments Ocular Surface and Contact Lens

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Ocular Pharmacology and Therapeutics

Volume 21, Issue 4, pp. 337-348

DOI: 10.1089/jop.2005.21.337

Field-Weighted Citation Impact: 4.99